Independent Analytical Programme
Certainty, measured.
Medutest procures peptides and research compounds under blind protocols, submits them to accredited commercial laboratories, and publishes every result — favourable or not. 16,294 samples across 198 vendors and 295 products, on the public record.
16,294
Samples assayed
198
Vendors on file
295
Products covered
The Current Tables
Updated 28 May 2026Tirzepatide(GLP-1 and GIP agonist)
I Tianjin Finder Chemical TFCA II Trusted PeptideA III Risynth BioA IV Aavant ResearchA V Nantong Guangyuan Chemical GYCARetatrutide(GLP-1, GIP, and GCGR agonist)
I Tianjin Finder Chemical TFCA II Bulk Peptide WholesaleA III Paradigm PeptideA IV NUPEPS PeptidesA V Peptide PartnersASemaglutide(GLP-1 agonist)
I Tianjin Finder Chemical TFCA II Bulk Peptide WholesaleA III InjectifyA IV Shanghai Sigma Audley SSAA V NextechLabsABPC-157(Bepecin)
I Tianjin Finder Chemical TFCA II Qingdao Sigma Chemical QSCA III Glbiochem (Shanghai)A IV Shanghai Sigma Audley SSAA V Wuhan Wansheng Bio (WWB)AEvery Medutest sample is taken through the complete panel — identity (LC-MS), purity (HPLC-UV), content & potency, heavy metals (ICP-MS), bacterial endotoxins (LAL) and sterility (USP <71>) — and any single failure is published in full, never averaged away. See the methodology, the statistics or the FAQ.